September 2026 Newsletter
The Care Coordination Gap: Connecting the Patient Journey
World Patient Safety Day provides an opportunity to examine a challenge that extends beyond any individual clinical decision: how healthcare systems coordinate care across the patient journey. The theme for World Patient Safety Day 2026 is “Safe care for noncommunicable diseases,” highlighting the patient-safety challenges associated with the long-term and complex care that NCDs often require.
Healthcare is increasingly delivered across multiple settings. A patient may move between primary care, specialists, hospitals, pharmacies and home-based care, often with different professionals responsible for different parts of their treatment. For people living with noncommunicable diseases (NCDs), this process can continue for years and involve repeated transitions between providers. When information, responsibilities or follow-up do not move with the patient, gaps can emerge. (1) The long-term and complex nature of NCD care, combined with frequent interactions with health systems, can increase exposure to potential harm.
However, the challenge extends beyond NCDs. Any patient moving between healthcare providers or settings can experience gaps in communication, information and follow-up. As healthcare becomes more distributed across hospitals, primary care, specialists, pharmacies and the home, continuity of care becomes an increasingly important part of patient safety.
Keeping information, treatment decisions and follow-up connected across these different points of care is essential to delivering safe, consistent care throughout the patient journey.
August 2026 Newsletter
Smarter Skin Cancer Detection: How AI Is Reshaping Dermatology
Sun Safety Month provides an opportunity to examine one of healthcare's fastest-evolving specialties: dermatology. While skin cancer remains one of the most common cancers worldwide, advances in artificial intelligence (AI), digital imaging, dermoscopy, and precision diagnostics are changing how clinicians detect and manage disease. As demand for dermatology services continues to grow alongside workforce shortages, these technologies are creating new opportunities to improve diagnostic accuracy, prioritise high-risk patients, and support earlier intervention.
July 2026 Newsletter
Advancing Brain Health: The Shift Towards Earlier Detection and Precision Care
World Brain Day provides an opportunity to examine a major shift in neurological care: the move towards earlier detection and intervention. Historically, many neurological conditions have been diagnosed after significant symptoms emerge, when treatment options are often limited. Advances in biomarkers, artificial intelligence (AI), neuroimaging, and digital health are now creating new opportunities to identify disease earlier, monitor progression more accurately, and develop more personalized treatment strategies.
This shift is particularly important as the global burden of neurological disease continues to increase. From neurodegenerative disorders to stroke and autoimmune neurological conditions, clinicians are increasingly looking for approaches that move beyond symptom management towards earlier risk identification and prevention. For healthcare systems and clinicians, the challenge is translating these advances into routine clinical practice.
June 2026 Newsletter
The Diagnostic Blind Spot: Why Men Are Still Entering Care Too Late
Men’s Health Month offers an important opportunity to examine one of healthcare’s most persistent, and overlooked, challenges: men are still entering care too late.
Across multiple disease categories, men are less likely to engage in preventative care, less likely to participate in routine screening, and more likely to delay medical attention when symptoms emerge. The result is a troubling pattern of later-stage diagnoses, fragmented care pathways, and preventable disease burden. While conversations around men’s health often focus on longevity or cardiovascular disease, a deeper systems issue deserves great attention: the diagnostic blind spot.
This blind spot is not limited to one condition. It spans cancers, sleep disorders, metabolic dysfunction, and hormonal health, many of which remain underdiagnosed despite the availability of screening tools and increasingly sophisticated diagnostic technologies. At the same time, advances in biomarkers, artificial intelligence (AI), home diagnostics, and decentralized care models are beginning to create new opportunities for earlier intervention.
Global Health Impact Network and Sojo.consulting formalize European partnership
GHIN & Sojo.consulting Announce a European Partnership
We are pleased to announce the formal European partnership between Global Health Impact Network (GHIN) and Sojo.consulting, alongside the appointment of Wojciech (Voytek) Majewski as GHIN Regional Director, Europe. This collaboration establishes a boutique transatlantic medtech advisory that connects leading European founders directly with GHIN’s network of over 3,000 U.S. clinicians and subject-matter experts. By providing investment-grade clinical and commercial diligence to European investors and corporate partners, this venture bridges the gap between European medical technology development and U.S. market adoption. Building on nine months of successful joint pilot engagements, this structured operating model is designed to meaningfully strengthen the cross-Atlantic clinical pathway and investor credibility.
May 2026 Newsletter
Data Analytics Platforms & Remote Patient Monitoring
As healthcare continues shifting toward continuous, personalized, and preventative care, data analytics platforms are emerging as one of the most critical layers of modern healthcare infrastructure. From remote patient monitoring (RPM) systems and wearable devices to biomarker analysis and AI-powered clinical decision support, healthcare organizations are generating unprecedented amounts of patient data outside traditional clinical settings. The challenge is no longer simply collecting information, it is transforming fragmented physiological, behavioral, and molecular data into clinically actionable insights.
This evolution is accelerating alongside growing FDA activity around software-based healthcare technologies, particularly in remote patient monitoring, clinical decision support systems, and Software as a Medical Device (SaMD). As digital health platforms increasingly move beyond wellness applications into regulated clinical environments, developers and investors face a complex balancing act: building scalable, data-driven systems while navigating evolving regulatory expectations, clinical validation requirements, and integration challenges.